Daun Norman
Known title: DirectorCIK: 0001860800
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Garrett Motion (GTX) Highlighted as Cash‑Producing & Growth Stock. Garrett Motion was named one of the top cash‑producing stocks and also singled out by growth investors for its strong fundamentals. Analysts have highlighted the company’s solid earnings and cash flow, and it was included in a list of market‑beating stocks. The inclusion underscores investor interest in its automotive component business. Current technical signals show the stock near a key support level.
Transaction History
| PHIN | ▲ Buy | Grant | 10 | $0 | 9/18/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 8 | $0 | 6/23/2026 | View on chart |
| GTX | ▲ Buy | Grant | 4,505 | — | 5/28/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 2,140 | $0 | 5/22/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 3/20/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 12/12/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 15 | $0 | 9/12/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 21 | $0 | 6/16/2025 | View on chart |
| GTX | ▲ Buy | Grant | 13,417 | — | 5/22/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 3,299 | $0 | 5/21/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 21 | $0 | 3/14/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 12/13/2024 | View on chart |
| GTX | ▲ Buy | Grant | 1,651 | $0 | 10/1/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 18 | $0 | 9/13/2024 | View on chart |
| GTX | ▲ Buy | Grant | 1,572 | $0 | 7/1/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 20 | $0 | 6/14/2024 | View on chart |
| GTX | ▲ Buy | Grant | 15,927 | $0 | 5/29/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 3,261 | $0 | 5/9/2024 | View on chart |
| GTX | ▲ Buy | Grant | 1,348 | $0 | 4/1/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 90 | $0 | 3/15/2024 | View on chart |
| GTX | ▲ Buy | Grant | 1,417 | $0 | 1/2/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 114 | $0 | 12/15/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 125 | $0 | 9/22/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 8,142 | $0 | 7/18/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 4,749 | $0 | 7/18/2023 | View on chart |
| GTX | ▲ Buy | Grant | 17,178 | $0 | 5/24/2023 | View on chart |
| GTX | ▲ Buy | Grant | 19,576 | $0 | 5/26/2022 | View on chart |
| GTX | ▲ Buy | Grant | 5,810 | $0 | 3/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
UBS Lowers PHIN Target to $68, Keeps Neutral Rating
UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.
UBS Lowers PHIN Target to $68, Keeps Neutral Rating. UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.